About Gleb Kuznetsov
Form D filings for Manifold Biotechnologies from 2020 to 2024 list Gleb Kuznetsov as chief executive officer and director.
Gleb Kuznetsov first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Gleb Kuznetsov in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gleb Kuznetsov works with at each company, as listed on that company's latest Form D.
Manifold Biotechnologies, Inc. · Form D, Dec 3, 2024
JB
Jory Bell
Director
JH
Jeff Huber
Director
PO
Pierce Ogden
Executive officer and director
SK
Steven Kafka
Director
SH
Steven Holtzman
Director